Larry G. Johnson

5.8k total citations
43 papers, 3.7k citations indexed

About

Larry G. Johnson is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Larry G. Johnson has authored 43 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 15 papers in Molecular Biology and 12 papers in Epidemiology. Recurrent topics in Larry G. Johnson's work include Cystic Fibrosis Research Advances (20 papers), Neonatal Respiratory Health Research (19 papers) and Virus-based gene therapy research (9 papers). Larry G. Johnson is often cited by papers focused on Cystic Fibrosis Research Advances (20 papers), Neonatal Respiratory Health Research (19 papers) and Virus-based gene therapy research (9 papers). Larry G. Johnson collaborates with scholars based in United States, United Kingdom and France. Larry G. Johnson's co-authors include Richard C. Boucher, John C. Olsen, Carolyn B. Coyne, James M. Wilson, James R. Yankaskas, Todd M. Gambling, Johnny L. Carson, Barbara R. Grubb, John F. Engelhardt and K. L. Moore and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Larry G. Johnson

41 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Larry G. Johnson United States 27 1.7k 1.7k 1.1k 453 370 43 3.7k
Ziying Yan United States 39 2.6k 1.6× 918 0.6× 2.7k 2.4× 1.0k 2.3× 1.1k 3.0× 106 4.7k
Jeong S. Hong United States 30 2.9k 1.7× 1.6k 0.9× 2.7k 2.4× 535 1.2× 709 1.9× 65 5.5k
Andreas Hector Germany 26 1.2k 0.7× 1.8k 1.1× 288 0.3× 383 0.8× 286 0.8× 57 3.6k
Wilfried Dalemans Spain 32 1.7k 1.0× 1.4k 0.8× 700 0.6× 930 2.1× 1.3k 3.4× 64 4.6k
Sureshkumar Muthupalani United States 30 1.3k 0.8× 533 0.3× 287 0.3× 281 0.6× 256 0.7× 95 3.0k
Renato Ostuni Italy 23 1.7k 1.0× 237 0.1× 372 0.3× 342 0.8× 246 0.7× 34 4.9k
Anja Krause United States 25 973 0.6× 446 0.3× 469 0.4× 212 0.5× 160 0.4× 39 2.3k
Eef Parthoens Belgium 20 1.5k 0.9× 371 0.2× 187 0.2× 537 1.2× 166 0.4× 25 3.1k
Peter Steinberger Austria 41 1.2k 0.7× 230 0.1× 312 0.3× 420 0.9× 223 0.6× 154 5.1k
Naomi Taylor France 38 1.4k 0.8× 170 0.1× 669 0.6× 413 0.9× 294 0.8× 104 4.6k

Countries citing papers authored by Larry G. Johnson

Since Specialization
Citations

This map shows the geographic impact of Larry G. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry G. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry G. Johnson more than expected).

Fields of papers citing papers by Larry G. Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larry G. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry G. Johnson. The network helps show where Larry G. Johnson may publish in the future.

Co-authorship network of co-authors of Larry G. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Larry G. Johnson. A scholar is included among the top collaborators of Larry G. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larry G. Johnson. Larry G. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Johnson, Larry G., et al.. (2013). Nontuberculous Empyema Necessitatis. American Journal of Respiratory and Critical Care Medicine. 188(8). e65–e66. 1 indexed citations
3.
McKay, Tristan R., et al.. (2006). Influenza M2 envelope protein augments avian influenza hemagglutinin pseudotyping of lentiviral vectors. Gene Therapy. 13(8). 715–724. 80 indexed citations
4.
Everett, Ruth, et al.. (2005). Specific Modulation of Airway Epithelial Tight Junctions by Apical Application of an Occludin Peptide. Molecular Pharmacology. 69(2). 492–500. 27 indexed citations
5.
Coyne, Carolyn B., Todd M. Gambling, Richard C. Boucher, Johnny L. Carson, & Larry G. Johnson. (2003). Role of claudin interactions in airway tight junctional permeability. American Journal of Physiology-Lung Cellular and Molecular Physiology. 285(5). L1166–L1178. 246 indexed citations
6.
Coyne, Carolyn B., Carla M. P. Ribeiro, Richard C. Boucher, & Larry G. Johnson. (2003). Acute Mechanism of Medium Chain Fatty Acid-Induced Enhancement of Airway Epithelial Permeability. Journal of Pharmacology and Experimental Therapeutics. 305(2). 440–450. 35 indexed citations
7.
Coyne, Carolyn B., et al.. (2002). Regulation of Airway Tight Junctions by Proinflammatory Cytokines. Molecular Biology of the Cell. 13(9). 3218–3234. 248 indexed citations
8.
Johnson, Larry G.. (2001). Retroviral Approaches to Gene Therapy of Cystic Fibrosis. Annals of the New York Academy of Sciences. 953a(1). 43–52. 20 indexed citations
9.
Johnson, Larry G., John C. Olsen, Luigi Naldini, & Richard C. Boucher. (2000). Pseudotyped human lentiviral vector-mediated gene transfer to airway epithelia in vivo. Gene Therapy. 7(7). 568–574. 94 indexed citations
10.
Noone, Peadar G., Zhaoqing Zhou, Larry G. Johnson, et al.. (2000). Safety and Biological Efficacy of a Lipid–CFTR Complex for Gene Transfer in the Nasal Epithelium of Adult Patients with Cystic Fibrosis. Molecular Therapy. 1(1). 105–114. 99 indexed citations
11.
Johnson, Larry G., Raymond J. Pickles, Julia Morris, et al.. (1996). In Vitro Assessment of Variables Affecting the Efficiency and Efficacy of Adenovirus-Mediated Gene Transfer to Cystic Fibrosis Airway Epithelia. Human Gene Therapy. 7(1). 51–59. 31 indexed citations
12.
Knowles, Michael R., Zhaoqing Zhou, John C. Olsen, et al.. (1995). A Controlled Study of Adenoviral-Vector–Mediated Gene Transfer in the Nasal Epithelium of Patients with Cystic Fibrosis. New England Journal of Medicine. 333(13). 823–831. 433 indexed citations
13.
Teramoto, Shinji, et al.. (1995). Effect of Adenoviral Vector Infection on Cell Proliferation in Cultured Primary Human Airway Epithelial Cells. Human Gene Therapy. 6(8). 1045–1053. 71 indexed citations
14.
Johnson, Larry G.. (1995). Gene Therapy for Cystic Fibrosis. CHEST Journal. 107(2). 77S–83S. 21 indexed citations
16.
Grubb, Barbara R., Raymond J. Pickles, Hong Ye, et al.. (1994). Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans. Nature. 371(6500). 802–806. 310 indexed citations
17.
Boucher, Richard C., Michael R. Knowles, Larry G. Johnson, et al.. (1994). Gene Therapy for Cystic Fibrosis Using E1-Deleted Adenovirus: A Phase I Trial in the Nasal Cavity. University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. Human Gene Therapy. 5(5). 615–639. 93 indexed citations
18.
Olsen, John C., et al.. (1993). Retrovirus-mediated gene transfer to cystic fibrosis airway epithelial cells: effect of selectable marker sequences on long-term expression. Nucleic Acids Research. 21(3). 663–669. 33 indexed citations
19.
Johnson, Larry G., et al.. (1993). High-Efficiency Gene Transfer to Primary Monkey Airway Epithelial Cells with Retrovirus Vectors Using the Gibbon Ape Leukemia Virus Receptor. Human Gene Therapy. 4(2). 161–170. 22 indexed citations
20.
Johnson, Larry G., John C. Olsen, Balázs Sarkadi, et al.. (1992). Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis. Nature Genetics. 2(1). 21–25. 334 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026